{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:43:50Z","timestamp":1783608230980,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK120533"],"award-info":[{"award-number":["R01 DK120533"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jconrel.2021.11.029","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T12:14:48Z","timestamp":1637669688000},"page":"300-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury"],"prefix":"10.1016","volume":"341","author":[{"given":"Weimin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Seong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay M.","family":"Jogdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk W.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu J.","family":"Padanilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oupick\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.11.029_bb0005","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit. Care"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0010","first-page":"548","article-title":"Acute kidney injury: definition, epidemiology, and outcome","volume":"17","author":"Srisawat","year":"2011","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0015","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.288.20.2547","article-title":"Diuretics, mortality, and nonrecovery of renal function in acute renal failure","volume":"288","author":"Mehta","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0020","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0025","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1681\/ASN.2012030222","article-title":"Yes, AKI truly leads to CKD","volume":"23","author":"Hsu","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-med-050214-013407","article-title":"Acute kidney injury","volume":"67","author":"Zuk","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0040","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0045","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","article-title":"Acute kidney injury in sepsis","volume":"43","author":"Bellomo","year":"2017","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0050","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0060","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines--chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0065","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/ajkd.1998.v31.pm9631856","article-title":"Chemotactic factors and renal inflammation","volume":"31","author":"Rovin","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0070","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1111\/j.1523-1755.2004.09109.x","article-title":"Inflammatory cytokines in acute renal failure","author":"Ramesh","year":"2004","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0075","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.18632\/oncotarget.3217","article-title":"CXCR4 over-expression and survival in cancer: a system review and meta-analysis","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pharmthera.2017.05.012","article-title":"Emerging roles of the CXCL12\/CXCR4 axis in pancreatic cancer progression and therapy","volume":"179","author":"Sleightholm","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0085","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1523-1755.2005.00275.x","article-title":"Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury","volume":"67","author":"T\u00f6gel","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40495-015-0044-8","article-title":"Potential of CXCR4\/CXCL12 chemokine axis in cancer drug delivery","volume":"2","author":"Wang","year":"2016","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nri3049","article-title":"Homeostatic chemokine receptors and organ-specific metastasis","volume":"11","author":"Zlotnik","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1 is a ligand for LESTR\/fusin and blocks HIV-1 entry","volume":"382","author":"Bleul","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0105","doi-asserted-by":"crossref","first-page":"F459","DOI":"10.1152\/ajprenal.00146.2014","article-title":"Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors","volume":"308","author":"Yuan","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0110","doi-asserted-by":"crossref","first-page":"F783","DOI":"10.1152\/ajprenal.00685.2013","article-title":"CXCR\u2084antagonism as a therapeutic approach to prevent acute kidney injury","volume":"307","author":"Zuk","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pharmthera.2018.10.013","article-title":"P53 in kidney injury and repair: mechanism and therapeutic potentials","volume":"195","author":"Tang","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0120","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.onc.1210263","article-title":"Coping with stress: multiple ways to activate p53","volume":"26","author":"Horn","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0125","doi-asserted-by":"crossref","first-page":"12350","DOI":"10.1073\/pnas.1615159113","article-title":"Ironing out how p53 regulates ferroptosis","volume":"113","author":"Murphy","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0130","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2012.05.014","article-title":"p53 opens the mitochondrial permeability transition pore to trigger necrosis","volume":"149","author":"Vaseva","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0135","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","article-title":"The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity","volume":"20","author":"Xie","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0140","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1681\/ASN.2014030262","article-title":"Regulated cell death in AKI","volume":"25","author":"Linkermann","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0145","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00018-016-2202-5","article-title":"Regulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis?","volume":"73","author":"Ying","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0150","doi-asserted-by":"crossref","first-page":"F1140","DOI":"10.1152\/ajprenal.00262.2004","article-title":"Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity","volume":"287","author":"Jiang","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0155","doi-asserted-by":"crossref","first-page":"F1282","DOI":"10.1152\/ajprenal.00230.2007","article-title":"Activation and involvement of p53 in cisplatin-induced nephrotoxicity","volume":"293","author":"Wei","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0160","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury","volume":"20","author":"Molitoris","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0165","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1681\/ASN.2013121270","article-title":"Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury","volume":"25","author":"Ying","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0170","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1681\/ASN.2013080902","article-title":"Tubular p53 regulates multiple genes to mediate AKI","volume":"25","author":"Zhang","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1681\/ASN.2012050469","article-title":"p53 is renoprotective after ischemic kidney injury by reducing inflammation","volume":"24","author":"Sutton","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0180","doi-asserted-by":"crossref","first-page":"38868","DOI":"10.1038\/srep38868","article-title":"p53 activates miR-192-5p to mediate vancomycin induced AKI","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.ASN.0000040596.23073.01","article-title":"P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor","volume":"14","author":"Kelly","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0190","doi-asserted-by":"crossref","first-page":"F298","DOI":"10.1152\/ajprenal.00459.2014","article-title":"TIGAR regulates glycolysis in ischemic kidney proximal tubules","volume":"308","author":"Kim","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/mt.2011.221","article-title":"Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals","volume":"20","author":"Inaba","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nmat4497","article-title":"Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment","volume":"15","author":"Conde","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2014.10.031","article-title":"Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors","volume":"81","author":"Wang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118555","article-title":"Determinants of preferential renal accumulation of synthetic polymers in acute kidney injury","volume":"568","author":"Chen","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/mp800078a","article-title":"Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan","volume":"6","author":"Yuan","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10611860701289875","article-title":"Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier","volume":"15","author":"Yuan","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7150\/thno.9717","article-title":"Chitosan\/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice","volume":"5","author":"Yang","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119368","article-title":"Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis","volume":"219","author":"Yu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0235","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/nl504610d","article-title":"Mesoscale nanoparticles selectively target the renal proximal tubule epithelium","volume":"15","author":"Williams","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/HYPERTENSIONAHA.117.09843","article-title":"Selective nanoparticle targeting of the renal tubules","volume":"71","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.kint.2020.01.036","article-title":"Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury","volume":"98","author":"Han","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0250","doi-asserted-by":"crossref","first-page":"331ra339","DOI":"10.1126\/scitranslmed.aac9647","article-title":"Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury","volume":"8","author":"Alidori","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0255","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acscentsci.0c00763","article-title":"Kidney-targeted cytosolic delivery of siRNA using a small-sized mirror DNA tetrahedron for enhanced potency","volume":"6","author":"Thai","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0260","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/adhm.201400608","article-title":"Development of functional poly(amido amine) CXCR4 antagonists with the ability to mobilize leukocytes and deliver nucleic acids","volume":"4","author":"Wang","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/acsnano.9b03978","article-title":"Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA\/siRNA nanotherapy","volume":"14","author":"Xie","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201800234","article-title":"Cholesterol modification enhances antimetastatic activity and siRNA delivery efficacy of poly(ethylenimine)-based CXCR4 antagonists","volume":"18","author":"Wu","year":"2018","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biomaterials.2016.05.042","article-title":"Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis","volume":"101","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0280","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acs.molpharmaceut.5b00894","article-title":"Delivery of miR-200c mimic with poly(amido amine) CXCR4 antagonists for combined inhibition of cholangiocarcinoma cell invasiveness","volume":"13","author":"Xie","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0285","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/C5BM00003C","article-title":"Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes","volume":"3","author":"Wang","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0290","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1002\/anie.201203463","article-title":"Dual-function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion","volume":"51","author":"Li","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0295","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.1200718109","article-title":"Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane","volume":"109","author":"Zuckerman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0300","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.biomaterials.2012.11.058","article-title":"In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier","volume":"34","author":"Naeye","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0305","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1021\/nn403325f","article-title":"Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo","volume":"7","author":"Nelson","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0310","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.CIR.23.4.578","article-title":"Plasma heparin levels in normal man","volume":"23","author":"Engelberg","year":"1961","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0315","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1159\/000430247","article-title":"P53 contributes to cisplatin induced renal oxidative damage via regulating P66shc and MnSOD","volume":"37","author":"Yuan","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0320","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2215\/CJN.02070606","article-title":"Defining acute renal failure: RIFLE and beyond","volume":"1","author":"Van Biesen","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0325","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00134-006-0478-x","article-title":"Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria","volume":"33","author":"Bellomo","year":"2007","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000337487","article-title":"Acute kidney injury and mortality in hospitalized patients","volume":"35","author":"Wang","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0335","doi-asserted-by":"crossref","first-page":"F1802","DOI":"10.1152\/ajprenal.00152.2006","article-title":"Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier","volume":"292","author":"Andersson","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0340","doi-asserted-by":"crossref","first-page":"F1362","DOI":"10.1152\/ajprenal.00123.2006","article-title":"Nature of glomerular capillary permeability changes following acute renal ischemia-reperfusion injury in rats","volume":"291","author":"Rippe","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0345","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000477181","article-title":"Role of immune cells in acute kidney injury and repair","volume":"137","author":"Lee","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0350","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrneph.2014.180","article-title":"Immune cells in experimental acute kidney injury","volume":"11","author":"Jang","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2021.11.029_bb0355","article-title":"CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease","volume":"48","author":"De Filippo","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0360","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3389\/fimmu.2018.02159","article-title":"The role of CXC chemokine receptors 1-4 on immune cells in the tumor microenvironment","volume":"9","author":"Susek","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.029_bb0365","article-title":"SDF-1\/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.11.029_bb0370","first-page":"F1487","article-title":"Mouse model of ischemic acute kidney injury: technical notes and tricks","volume":"303","author":"Wei","year":"2012","journal-title":"Am. J. Physiol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:13:54Z","timestamp":1759162434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921006246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":74,"alternative-id":["S0168365921006246"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}